1. Home
  2. MXCT vs DMO Comparison

MXCT vs DMO Comparison

Compare MXCT & DMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • DMO
  • Stock Information
  • Founded
  • MXCT 1999
  • DMO 2009
  • Country
  • MXCT United States
  • DMO United States
  • Employees
  • MXCT N/A
  • DMO N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DMO Trusts Except Educational Religious and Charitable
  • Sector
  • MXCT Health Care
  • DMO Finance
  • Exchange
  • MXCT Nasdaq
  • DMO Nasdaq
  • Market Cap
  • MXCT 148.2M
  • DMO 135.9M
  • IPO Year
  • MXCT 2021
  • DMO N/A
  • Fundamental
  • Price
  • MXCT $1.45
  • DMO $11.93
  • Analyst Decision
  • MXCT Buy
  • DMO
  • Analyst Count
  • MXCT 4
  • DMO 0
  • Target Price
  • MXCT $7.50
  • DMO N/A
  • AVG Volume (30 Days)
  • MXCT 797.5K
  • DMO 49.6K
  • Earning Date
  • MXCT 11-05-2025
  • DMO 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • DMO 12.06%
  • EPS Growth
  • MXCT N/A
  • DMO N/A
  • EPS
  • MXCT N/A
  • DMO N/A
  • Revenue
  • MXCT $35,754,000.00
  • DMO N/A
  • Revenue This Year
  • MXCT N/A
  • DMO N/A
  • Revenue Next Year
  • MXCT $14.79
  • DMO N/A
  • P/E Ratio
  • MXCT N/A
  • DMO N/A
  • Revenue Growth
  • MXCT N/A
  • DMO N/A
  • 52 Week Low
  • MXCT $1.26
  • DMO $10.00
  • 52 Week High
  • MXCT $5.20
  • DMO $11.80
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 43.25
  • DMO 54.52
  • Support Level
  • MXCT $1.39
  • DMO $11.89
  • Resistance Level
  • MXCT $1.49
  • DMO $11.98
  • Average True Range (ATR)
  • MXCT 0.06
  • DMO 0.06
  • MACD
  • MXCT 0.04
  • DMO 0.01
  • Stochastic Oscillator
  • MXCT 76.47
  • DMO 78.26

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About DMO Western Asset Mortgage Opportunity Fund Inc.

Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.

Share on Social Networks: